About MedGenome

Advancing precision medicine and healthcare equity

MedGenome is a leader in comprehensive multiomics solutions with a global footprint and deep capabilities in research and sequencing services, diagnostics and bioinformatics.

Comprehensive next generation sequencing services

Top genomics research service provider in the San Francisco Bay Area

MedGenome Timeline

MedGenome's California headquarters has state-of-the-art Next Generation Sequencing (NGS) platforms for high-throughput sequencing services. Our service offerings include RNA, whole genome, epigenome, whole exome and targeted sequencing. In addition, MedGenome offers single cell sequencing, spatial transcriptomics and antibody discovery services using the 10X Genomics platform. Our services are supported by robust bioinformatics pipelines to generate high quality insights.

Global reach, near you

Core facilities in US, India and Singapore

We serve academic and industry researchers across 35+ countries including South America, the Middle East and Africa.

MedGenome Locations

Advancing precision medicine can reduce healthcare disparities and improve patient outcomes. MedGenome is a founding member of the GenomeAsia 100K, an initiative to sequence 100,000 genomes in Asia, making us a unique resource of genetic research for the world. We deliver benefits to all stakeholders within the global research community with our network of clinicians and hospitals, proprietary tools, and scientific expertise. Our access to untapped genomic data from diverse ethnicities from previously underserved regions such as LATAM, Africa, the Middle East, and Asia enables us to accelerate disease biology research and biomarker discovery.


Join our team of scientific and bioinformatics experts

MedGenome offers a vibrant research environment utilizing NGS. We provide exciting and challenging opportunities to enhance and expand one's skill sets and the flexibility to work across teams.


Featured articles

Grant Winner Dr. Lauren Esposito


MedGenome announces de novo Genome Assembly and Annotation Grant winners for 2024
Foster City Award


MedGenome Inc., honored with the Best of Foster City Award six times in a row
Martin Dewhurst MedGenome


MedGenome appoints Martin Dewhurst as Chairman of Advisory Board
10X Certified MedGenome


MedGenome achieves 10x Genomics Certified Service provider qualification for single cell sequencing
MedGenome Pharma Partneship


MedGenome ties-up with Emmes to bridge gaps in rare diseases
MedGenome Grant


MedGenome, in collaboration with PacBio, announces a de novo genome assembly and annotation grant
Biomarker Discovery Research


Gallbladder cancer vaccine candidates identified
©2024 MedGenome | All rights reserved | Terms & conditions | Privacy policy
Request a quote